BOP faces scrutiny over exclusive deal to sell nicotine pouches to prisoners

The Federal Bureau of Prisons (BOP) is facing heightened scrutiny following a newly established exclusive arrangement in July. Under this agreement, a Florida-based start-up has been granted the sole right to sell nicotine pouches to inmates within the federal prison system.

The controversy centers on the regulatory status of the products being sold. According to reports, the nicotine pouches distributed through the exclusive deal have not received authorization from the Food and Drug Administration (FDA).